JEBBERZ that link isn't even clickable
The better Project is Project S having a NPV of $17.968 and IRR of 12.10 %
IRR:
- An approach to capital budgeting that is used to assess the profitability of a project is the discounted payback time. Internal rate of return is one of these capital planning strategies (IRR).
- This rate of return corresponds to the point at which a project's net present value equals zero. Since it does not account for any outside forces, such as inflation, they call it internal.
The calculator's capabilities will be utilized to determine the IRR,
Project S
- CF0 = (1,000)
- CF1 = 882.62 & F01 = 1
- CF2 = 250 & F02 = 1
- CF3 = 15 & F03 = 1
- CF4 = 5 & F04 = 1
- I = 10.5%
- [NPV] [CPT]
- The NPV is $17.968
- [IRR] [CPT]
- The IRR will come as 12.10%
- Project L
- CF0 = (1,000)
- CF1 = 0 & F01 = 1
- CF2 = 260 & F02 = 1
- CF3 = 420 & F03 = 1
- CF4 = 732.87 & F04 = 1
- I = 10.5%
- [NPV] [CPT]
- The NPV is $15.78
- [IRR] [CPT]
- The IRR will come as 11.03%
- The better Project is Project S having a NPV of $17.968 and IRR of 12.10%
Learn more about IRR here brainly.com/question/7920964
#SPJ4
Answer:
$4,424
Explanation:
Calculation for her employer's after-tax cost of providing the health insurance
Using this formula
After-tax cost =Annually employer's cost of health insurance -(=Annually employer's cost of health insurance*Marginal tax rate)
Let plug in the formula
After-tax cost =$5,600- ($5,600 × 21%)
After-tax cost =$5,600- $1,176
After-tax cost =$4,424
Therefore her employer's after-tax cost of providing the health insurance is $4,424
Any contract Fay enters into is "voidable if the other party does not realize that Fay is incompetent".
Business contract law holds that people that have been proclaimed mentally uncouth in a courtroom may discover an agreement they go into announced void, voidable, or enforceable. The guardian is the main individual who can go into an agreement for the incompetent individual's behalf.
<u>TRUE</u>
<em>Ewing Marion Kauffman was an entrepreneur who invented a number of new drugs for the healthcare industry.</em>
<em><u></u></em>